LYZ and amyloidosis: We have previously established a Drosophila melanogaster model for lysozyme amyloidosis to investigate in vivo behaviour of disease-associate lysozyme variants using the ubiquitous and retinal drivers Act5C-Gal4 and gmr-Gal4 [14].